ESSA PHARMA INC.

Analyst Reco. ESSA Pharma Inc. Toronto S.E.

Equities

CA29668H7085

End-of-day quote Toronto S.E. Other stock markets			5-day change	1st Jan Change
- ^CAD	-.--%		-.--%	-.--%

05-20	Top Premarket Decliners	MT
05-14	ESSA Pharma Inc. Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024	CI

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Oppenheimer Adjusts ESSA Pharma's Price Target to $17 From $23, Maintains Outperform Rating	22-12-14	MT
Oppenheimer Adjusts ESSA Pharma Price Target to $23 From $22, Maintains Outperform Rating	22-06-28	MT
Piper Sandler Adjusts ESSA Pharma's Price Target to $20 From $50, Reiterates Overweight Rating	22-05-12	MT
ESSA PHARMA : Oppenheimer Adjusts ESSA Pharma PT to $22 From $36 on Delayed EPI-7386 Clinical Update, Maintains Outperform Rating	21-08-17	MT
ESSA PHARMA : Piper Sandler Starts ESSA Pharma at Overweight With $50 Price Target	21-03-04	MT
ESSA PHARMA : HC Wainwright Adjusts ESSA Pharma PT to $32 From $36, Maintains Buy Rating	21-02-25	MT
ESSA PHARMA : Oppenheimer Adjusts ESSA Pharma PT to $36 From $20, Maintains Outperform Rating	21-02-12	MT
ESSA PHARMA : HC Wainwright & Co. Adjusts Price Target on ESSA Pharma to $36 From $17, Maintains Buy Rating	21-02-11	MT
ESSA PHARMA : Oppenheimer Adjusts ESSA Pharma PT to $20 From $9, Maintains Outperform Rating	21-01-14	MT
ESSA PHARMA : Jefferies Starts ESSA Pharma at Buy With $17 Price Target	20-11-02	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

The best tools reserved for subscribers to boost the performance of your investments!

Optimize my profits

fermer